F.D.A. Approves New Eli Lilly Obesity Pill, Foundayo - The New York Times

F.D.A. Approves New Eli Lilly Obesity Pill, Foundayo  The New York TimesAnother GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it’s used  CNNFDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions  Eli LillyOral Alternative to Ozempic May Be Even More Effective For Weight Loss  ScienceAlertFDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market  CNBC